Veranstaltungskalender
H.H. Bartsch, Charalampos Chrelias, Marco-Johannes Battista, Michael Ståhl(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Ioannis Salloum, Rainer Claus(University of Augsburg), Georgios Chrelias, Leopold Sellner(National Center for Tumor Diseases), Georgia Manousopoulou, Andreas Stephan Lübbe, Hans-Rudolf Raab, Tanja Zimmermann, Sujuan Gao, Florian Scherer, Petra Voiß, Bin Liu, Gerald Kolb(Philipps University of Marburg), Shuofeng Li, Georgios‐Marios Makris
Cited by 0
Related Papers
Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis
|Genes & Development|2009|351
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2020|202
Sch9 regulates ribosome biogenesis via Stb3, Dot6 and Tod6 and the histone deacetylase complex RPD3L
|The EMBO Journal|2011|179
Hsp90 is regulated by a switch point in the C‐terminal domain
|EMBO Reports|2009|173
Decrease in plasma membrane tension triggers PtdIns(4,5)P2 phase separation to inactivate TORC2
|Nature Cell Biology|2018|151